An underground market for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.
Investigational Drug Gaining Traction Via Social Media
Retatrutide, which remains in research studies, is being advertised by social media influencers for its supposed weight-reducing effects. Followers are encouraged to contact these accounts directly for supplier links, while also obtaining discount codes.
Active Trade on Social Networks
Separately, a flourishing trade exists on Telegram, where groups with thousands of members share “before and after” photos, administration instructions and assertions of rapid UK delivery. Vendors market the drug there before directing customers to other platforms for purchases.
Learning About The Experimental Drug
This medication is an investigational injection created by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.
Medical Professionals Voice Worries
However, physicians and pharmacists have cautions that the distribution of what remains an unlicensed drug in the United Kingdom is a cause for concern and could result in users administering substances of unknown origin.
Some experts said the popularity for the experimental drug could be linked to the increasing price of licensed weight loss products such as Mounjaro.
Legal Status and Implementation
Selling the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that must not be marketed or supplied for personal consumption under the British medical regulations.
Some influencers try to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still violate pharmaceutical, marketing, and customer regulations, potentially leading to fines, prosecution or prison.
Service Reaction and Content Removal
Based on TikTok, the service has taken down problematic content and banned related hashtags and search suggestions. The company stated it was committed to keeping the platform safe and investing in enhancing compliance measures.
Digital Marketplace Activities
Research also discovered groups with up to 9,000 members marketing retatrutide using the platform's integrated search feature, which operates like a public directory. Entering “retatrutide” immediately brings up groups with thousands of users, filled with photos of slimming results, glowing reviews and detailed instructions for mixing or administering at residence.
After moments of entering one community, a seller posted WhatsApp details, where the majority of transactions take place. The vendor provided an instruction manual and promised shipping within two days. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. None asked about weight, health issues or previous experience.
Product Information and Pricing
Within these groups, posts show black plastic parcels with postal service stickers, stating to include new batches. One communication read: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at residence with sterile water, or pre-filled injectors typically priced at 160 pounds for 20 milligrams. When asked how much time a injector should last, sellers give contradictory responses varying between a several days to “depends on your body”.
Service Moderation and Safety Actions
A spokesperson for the messaging service stated it regularly monitored dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Warnings
“People are injecting substances they cannot confirm. Although the research behind retatrutide is sound, these online versions may not include what they advertise,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.
A medical professional of an online medical service connected the increase in demand to current cost increases for authorized weight-loss drugs such as Mounjaro. “With costs rising, patients are using social media. But counterfeit treatments are highly risky. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she explained.
Her team has previously encountered patients injured by self-injection from unconfirmed sources. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”
Producer Position
A spokesperson from Eli Lilly stated the substance was in phase 3 research studies and had not been evaluated or approved by any government authority globally. “Therefore at this point no one can market [it] for personal consumption,” they said, noting that any item “misleadingly claiming itself as a Lilly experimental product not yet authorized … may expose patients to potentially serious health risks”.
